Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Recept Signal Transduct Res ; 38(1): 76-82, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-29369009

RESUMEN

INTRODUCTION/AIMS: In recent years, it has been shown that free fatty acids receptors (FFAR) of whose function in the cell surface plays a significant role in the regulation of cell function and nutrition as well are activated by various endogenous ligands, but mainly by fatty acids. Within FFAR of our interest are GPR 41, 43 and 120. The functions of these receptors are varied and dependent on the tissue where they are. The activation and signaling of these receptors, FFAR, are involved in many physiological processes, and currently the target of many drugs in metabolic disorders like obesity, diabetes and atherosclerosis. MATERIAL AND METHODS: Obesity was induced with hypercaloric diet (HD) in male Wistar rats for 20 weeks (n = 10). At the end, adipose tissue (abdominal and subcutaneous) was taken to perform assays for relative quantification mRNA expression by end-point RT-PCR and protein level expression by Western blot. RESULTS: These present data have shown for the first time that total mRNA isolation and protein expression from both adipose tissues (abdominal and subcutaneous) of rat in obesity condition yield significative statistical difference among the control versus obese groups, showing that the diet high in carbohydrates modifies the total presence of mRNA and protein level expression of the receptors GPR41, 43 and 120. CONCLUSIONS: Further comparative methods are in process to clarify whether or not the obesity changes the functional receptors in these two tissues for new pharmacological approaches.


Asunto(s)
Obesidad/tratamiento farmacológico , Obesidad/genética , Receptores Acoplados a Proteínas G/genética , Tejido Adiposo/metabolismo , Animales , Aterosclerosis/tratamiento farmacológico , Aterosclerosis/patología , Diabetes Mellitus/tratamiento farmacológico , Diabetes Mellitus/patología , Dieta Alta en Grasa , Modelos Animales de Enfermedad , Ácidos Grasos no Esterificados/genética , Ácidos Grasos no Esterificados/metabolismo , Regulación de la Expresión Génica/genética , Humanos , Insulina/genética , Insulina/metabolismo , Obesidad/metabolismo , Obesidad/patología , Ratas , Receptores Acoplados a Proteínas G/metabolismo
2.
Endocr Res ; 42(3): 252-259, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28318332

RESUMEN

PURPOSE: The aim of this study was to investigate the possible relationship among insulin resistance (IR), endothelial dysfunction, and alteration of adipokines in Mexican obese adolescents and their association with metabolic syndrome (MetS). MATERIALS AND METHODS: Two hundred and twenty-seven adolescents were classified according to the body mass index (BMI) (control: N=104; obese: N=123) and homeostasis model of the assessment-insulin resistance index (HOMA-IR) (obese with IR: N=65). The circulating concentrations of leptin, adiponectin, soluble intercellular adhesion molecule-1 (sICAM-1), and IR were determined by standard methods. RESULTS: The obese adolescents with IR presented increased presence of MetS and higher circulating concentrations in sICAM-1 in comparison with the obese subjects without IR. The lowest concentrations of adiponectin were observed in the obese with IR. In multivariate linear regression models, sICAM-1 along with triglycerides, total cholesterol, and waist circumference was strongly associated with HOMA-IR (R2=0.457, P=0.008). Similarly, after adjustment for age, BMI-SDS, lipids, and adipokines, HOMA-IR remained associated with sICAM-1 (R2=0.372, P=0.008). BMI-SDS was mildly associated with leptin (R2=0.176, P=0.002) and the waist circumference was mild and independent determinant of adiponectin (R2=0.136, P=0.007). CONCLUSIONS: Our findings demonstrated that the obese adolescents, particularly the obese subjects with IR exhibited increased presence of MetS, abnormality of adipokines, and endothelial dysfunction. The significant interaction between IR and endothelial dysfunction may suggest a novel therapeutic approach to prevent or delay systemic IR and the genesis of cardiovascular diseases in obese patients.


Asunto(s)
Adipoquinas/sangre , Endotelio Vascular/fisiopatología , Resistencia a la Insulina/fisiología , Síndrome Metabólico/sangre , Obesidad Infantil/sangre , Adolescente , Niño , Comorbilidad , Femenino , Humanos , Masculino , Síndrome Metabólico/epidemiología , Síndrome Metabólico/fisiopatología , México/epidemiología , Obesidad Infantil/epidemiología , Obesidad Infantil/fisiopatología
3.
J Sci Food Agric ; 97(13): 4451-4458, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28276068

RESUMEN

BACKGROUND: Obesity is associated with increased risk of a number of serious medical conditions, including urological disorders. This study investigated the effect of lipidic extracts of saladette tomato pomace (STP) and Serenoa repens (SR) on the prostate and bladder in a rat obese model induced by high-carbohydrate diet. RESULTS: High-sucrose-fed rats showed higher prostate weight as well as increased contractility and stromal and epithelial hyperplasia in the prostate. Treatment with STP and SR improved contractility and diminished hyperplasia and hypertrophy in the prostate. Obese animals also showed impaired bladder contractility, but neither extract reversed this deterioration. In the histological study, a disarray in the process of smooth muscle cell proliferation with non-parallel fibers was observed; interestingly, treatment with STP and SR led to improvement in this derangement. CONCLUSION: These findings indicated impaired contractility and hyperplasia in the prostate and bladder of obese rats induced by high sucrose. STP and SR could enhance prostate function by reducing contractility and hyperplasia and improve smooth muscle fiber structure and decrease cell proliferation in the bladder, suggesting their possible health-beneficial effects on lower urinary tract symptoms. © 2017 Society of Chemical Industry.


Asunto(s)
Obesidad/complicaciones , Extractos Vegetales/administración & dosificación , Próstata/efectos de los fármacos , Serenoa/química , Solanum lycopersicum/química , Vejiga Urinaria/efectos de los fármacos , Animales , Humanos , Masculino , Obesidad/metabolismo , Próstata/fisiopatología , Enfermedades de la Próstata/tratamiento farmacológico , Enfermedades de la Próstata/etiología , Enfermedades de la Próstata/metabolismo , Enfermedades de la Próstata/fisiopatología , Ratas , Ratas Wistar , Vejiga Urinaria/fisiopatología , Enfermedades de la Vejiga Urinaria/tratamiento farmacológico , Enfermedades de la Vejiga Urinaria/etiología , Enfermedades de la Vejiga Urinaria/metabolismo , Enfermedades de la Vejiga Urinaria/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA